We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in Genomic Health, Inc. in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 219 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 221 → 0 (-221)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $2.44B → $0 (-$2.44B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 219

Holders
–
Holders Change
-221
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
219
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$627M
2
BlackRock
BlackRock
New York
-$276M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$187M
4
Renaissance Technologies
Renaissance Technologies
New York
-$170M
5
State Street
State Street
Massachusetts
-$98.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
KC
101
Kepos Capital
New York
– -$1.11M -16,443 Closed
PI
102
PineBridge Investments
New York
– -$1.1M -16,260 Closed
State of Tennessee, Department of Treasury
103
State of Tennessee, Department of Treasury
Tennessee
– -$1.09M -16,042 Closed
RJA
104
Raymond James & Associates
Florida
– -$1.06M -15,575 Closed
VOYA Investment Management
105
VOYA Investment Management
Georgia
– -$1.04M -15,321 Closed
TPSF
106
Texas Permanent School Fund
Texas
– -$998K -14,721 Closed
SO
107
STRS Ohio
Ohio
– -$983K -14,500 Closed
Jennison Associates
108
Jennison Associates
New York
– -$971K -14,322 Closed
State Board of Administration of Florida Retirement System
109
State Board of Administration of Florida Retirement System
Florida
– -$939K -13,841 Closed
ProShare Advisors
110
ProShare Advisors
Maryland
– -$929K -13,694 Closed
DCM
111
Dupont Capital Management
Delaware
– -$904K -13,332 Closed
EAM
112
Erste Asset Management
Austria
– -$851K -12,400 Closed
MIM
113
MetLife Investment Management
New Jersey
– -$834K -12,302 Closed
UONDDL
114
University of Notre Dame du Lac
Indiana
– -$818K -12,063 Closed
Assenagon Asset Management
115
Assenagon Asset Management
Luxembourg
– -$789K -11,631 Closed
Voloridge Investment Management
116
Voloridge Investment Management
Florida
– -$736K -10,848 Closed
Mirae Asset Global Investments
117
Mirae Asset Global Investments
South Korea
– -$718K -10,588 Closed
Envestnet Asset Management
118
Envestnet Asset Management
Illinois
– -$717K -10,573 Closed
Victory Capital Management
119
Victory Capital Management
Texas
– -$657K -9,693 Closed
First Trust Advisors
120
First Trust Advisors
Illinois
– -$646K -9,518 Closed
EU
121
Emory University
Georgia
– -$645K -9,506 Closed
Jane Street
122
Jane Street
New York
– -$611K -9,007 Closed
MLICM
123
Metropolitan Life Insurance Company (MetLife)
New York
– -$604K -8,900 Closed
New York State Teachers Retirement System (NYSTRS)
124
New York State Teachers Retirement System (NYSTRS)
New York
– -$588K -8,670 Closed
OPERF
125
Oregon Public Employees Retirement Fund
Oregon
– -$583K -8,600 Closed
3 4
5
6 7

GHDX Hedge Fund Activity: Q4 2019 in Review

0 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q4 2019, worth a combined $0 — down 100% from $2.44B a quarter earlier.

Sellers outnumbered buyers: 219 funds closed out of GHDX and 0 opened new positions — a net loss of 219 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $627M sold.

  • 0 institutional investors held Genomic Health, Inc. (GHDX) as of Q4 2019, down from 221 in Q3 2019.
  • Funds reported $0 of Genomic Health, Inc. stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Genomic Health, Inc. positions in Q4 2019 and 219 closed out, a net change of -219 holders.
  • The largest Genomic Health, Inc. seller in Q4 2019 was Baker Bros. Advisors, an estimated $627M sold.

Based on aggregated 13F filings for Q4 2019.